Liming Chen

Nov 22, 2024 | mdpi.com | Bowen Feng |Liming Chen |Liangmin Huang |Jun Li

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Oct 11, 2024 | dx.doi.org | Jia Chen |Zhilin Chen |Xianbo Hou |Liming Chen

Jun 28, 2024 | weforum.org | Liming Chen

Innovation and international collaboration are crucial in addressing global challenges but uneven levels of innovation across regions can hinder global development and economic growth. China has emerged as a major driver of global innovation, significantly increasing its research and development expenditure and leading in patent applications.

Dec 13, 2023 | nature.com | Linong Ji |Liming Chen |Shen Qu

AbstractMazdutide is a once-weekly glucagon-like peptide-1 (GLP-1) and glucagon receptor dual agonist. We evaluated the efficacy and safety of 24-week treatment of mazdutide up to 6 mg in Chinese overweight adults or adults with obesity, as an interim analysis of a randomised, two-part (low doses up to 6 mg and high dose of 9 mg), double-blind, placebo-controlled phase 2 trial (ClinicalTrials.gov, NCT04904913).

Jun 21, 2023 | yicaiglobal.com | Liming Chen |Long Chen

(Yicai Global) June 21 -- The latest report by the Intergovernmental Panel on Climate Change (IPCC) has made it clear: the window we have to safeguard our society from catastrophic climate disasters is fast closing if we do not act now. And if we don’t innovate new approaches to expedite greenhouse gas (GHG) mitigation in the next seven years, we will lose.